SII seeks govt’s nod to manufacture, stockpile qHPV vaccine against cervical cancer, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The Serum Institute of India (SII) will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI) for the Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer., The Serum Institute of India (SII) will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI) for the Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer., , Read More